exploring

This post is co-written with Joe Clark from Domo. Data insights are crucial for businesses to enable data-driven decisions, identify trends, and optimize operations. Traditionally, gaining these insights required skilled analysts using specialized tools, which can make the process slow and less accessible. Generative artificial intelligence (AI) has revolutionized thisContinue Reading

Zhanna Hapanovich TRACON Pharmaceuticals (OTC:TCON) said it is discontinuing development of its oncology drug candidate envafolimab after a key clinical trial failed to meet its primary endpoint and will concentrate instead on exploring strategic alternatives for the company. TRACON said that the study, ENVASARC, failed to meet its primary endpointContinue Reading